Banco Bilbao Vizcaya Argentaria’s Bristol-Myers Squibb BMY Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.9M	Sell	543,291 -98,196	-15%	-$5.72M	0.23%	71
2025 Q4	$34.6M	Sell	641,487 -14,852	-2%	-$714K	0.24%	72
2025 Q3	$29.6M	Buy	656,339 +18,244	+3%	+$852K	0.23%	76
2025 Q2	$29.5M	Buy	638,095 +15,599	+3%	+$766K	0.27%	70
2025 Q1	$38M	Buy	622,496 +812	+0.1%	+$47.3K	0.38%	55
2024 Q4	$35.2M	Sell	621,684 -13,223	-2%	-$739K	0.37%	50
2024 Q3	$32.8M	Buy	634,907 +117,836	+23%	+$5.53M	0.33%	61
2024 Q2	$21.5M	Sell	517,071 -100,938	-16%	-$4.52M	0.23%	92
2024 Q1	$33.2M	Buy	618,009 +27,388	+5%	+$1.4M	0.38%	53
2023 Q4	$30.3M	Buy	590,621 +145,607	+33%	+$7.64M	0.36%	63
2023 Q3	$25.7M	Sell	445,014 -65,341	-13%	-$4M	0.35%	68
2023 Q2	$32.6M	Sell	510,355 -12,766	-2%	-$856K	0.42%	52
2023 Q1	$36.3M	Buy	523,121 +2,553	+0.5%	+$180K	0.45%	53
2022 Q4	$37.5M	Buy	520,568 +37,397	+8%	+$2.82M	0.55%	35
2022 Q3	$34.3M	Sell	483,171 -19,852	-4%	-$1.44M	0.55%	38
2022 Q2	$38.7M	Buy	503,023 +39,130	+8%	+$2.98M	0.58%	29
2022 Q1	$34.4M	Buy	463,893 +172,484	+59%	+$11.6M	0.46%	44
2021 Q4	$18.2M	Buy	291,409 +121,883	+72%	+$7.15M	0.24%	83
2021 Q3	$10.1M	Buy	169,526 +20,039	+13%	+$1.32M	0.16%	115
2021 Q2	$9.89M	Buy	149,487 +7,866	+6%	+$513K	0.18%	107
2021 Q1	$8.91M	Buy	141,621 +14,915	+12%	+$928K	0.18%	105
2020 Q4	$7.86M	Buy	126,706 +34,094	+37%	+$2.1M	0.18%	102
2020 Q3	$5.58M	Sell	92,612 -5,137	-5%	-$309K	0.16%	115
2020 Q2	$5.75M	Sell	97,749 -18,919	-16%	-$1.13M	0.18%	96
2020 Q1	$6.5M	Buy	116,668 +10,847	+10%	+$663K	0.23%	87
2019 Q4	$6.79M	Buy	+105,821	New	+$6.06M	0.21%	91

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's BMY Position: Q1 2026 in Review

Banco Bilbao Vizcaya Argentaria reduced its Bristol-Myers Squibb (BMY) stake by 15% in Q1 2026, selling an estimated $5.72M and leaving 543,291 shares worth $32.9M. The position accounts for 0.23% of the portfolio, ranked #71.

Banco Bilbao Vizcaya Argentaria first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. The position peaked at $38.7M in Q2 2022. 2,524 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Banco Bilbao Vizcaya Argentaria held 543,291 shares of Bristol-Myers Squibb worth $32.9M as of Q1 2026.
Banco Bilbao Vizcaya Argentaria sold 98,196 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.72M.
Bristol-Myers Squibb made up 0.23% of Banco Bilbao Vizcaya Argentaria's portfolio in Q1 2026, its #71 holding.
Banco Bilbao Vizcaya Argentaria first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
Banco Bilbao Vizcaya Argentaria's Bristol-Myers Squibb position peaked at $38.7M in Q2 2022.
2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q1 2026, filed 14 May 2026.